Related Experiment Video
Updated: Jul 14, 2026
13:19
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Emerging targeted therapies for breast cancer
Monica Arnedos1, Andrew D Seidman
1Breast Unit, Department of Medicine, The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. monica.arnedos@rmh.nhs.uk
Hematology/Oncology Clinics of North America
|May 22, 2007
Summary
Breast cancer, a common women's cancer, is increasingly targeted by new therapies. Research focuses on agents that block molecular targets involved in cancer growth and spread.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Breast cancer is the most prevalent neoplasia globally among women.
- Intracellular signaling pathways are frequently activated or overexpressed in breast cancer patients.
- Targeted therapies represent a rapidly advancing field in cancer treatment.
Purpose of the Study:
- To review the development of agents targeting molecular pathways in breast cancer.
- To highlight the significance of intracellular signaling in breast cancer progression.
- To discuss the promise of targeted therapies in oncology.
Main Methods:
- Review of experimental data on intracellular signaling pathways in breast cancer.
- Analysis of current research trends in targeted therapy development.
- Synthesis of information on molecular targets in breast cancer treatment.
Main Results:
- Experimental evidence supports the role of specific intracellular signaling pathways in breast cancer.
- Targeted agents are being developed to interfere with these pathways.
- These targeted therapies show significant promise in preclinical and clinical settings.
Conclusions:
- Targeted therapies offer a promising new avenue for breast cancer treatment.
- Understanding molecular targets is crucial for advancing breast cancer care.
- Continued research in this area is essential for improving patient outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...